Air Liquide Venture Capital (ALIAD)

Air Liquide Investments in the future and demonstration (ALIAD), is a 100% Air Liquide subsidiary integrated in the Group’s new network Advanced Business and Technologies entrepreneurial companies. ALIAD contributes to the Group’s growth and competitiveness by investing in young innovative companies offering new technologies. By placing investments in a dedicated subsidiary, Air Liquide ensures itself all the means for developing these projects with the necessary flexibility and reactivity.

Aurélie Schwartzmann

Investment Director

13 past transactions

Inpria

Series C in 2020
Inpria Corporation is a pioneer in extending semiconductor lithography with inorganic photoresists and other thin-films for nanoscale patterning. Inpria’s patented photo-condensed molecular oxides offer customers the unique ability to deposit – directly from solution – atomically smooth, intrinsically dense, and directly photopatternable metal oxide films, enabling advanced performance with simplified processing.

Diabeloop

Series B in 2019
Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes. The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015 and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France.

Ergosup

Series B in 2019
Ergosup developes an innovative process for producing high pressure hydrogen on site for refueling hydrogen fuel vehicles.

MYSPHERA

Venture Round in 2018
MYSPHERA provides award-winning open Internet of Things for Healthcare solutions to acute care hospitals, senior living organizations, and patient homes around the world. MYSPHERA solutions empower Clinicians, Patients, and Healthcare Management with smart sensor-driven on-demand actionable information to improve patient care outcomes while increasing efficient management of resources in hospitals, senior living residences, and patient homes MYSPHERA provides its breathrough solutions to healthcare organizations in Europe, Middle East and Latin America.

aveni

Series B in 2017
aveni delivers innovative metallization processes that improve device performance and yield, enabling future technologies, today. Their production-ready solutions revolutionize the copper-plating process for damascene and TSV applications critical to semiconductor and MEMS device manufacturing. aveni’s Electrografting (eG™) technology is a wet, electrochemical-based process that enables the growth of extremely high-quality thin films of various types. Chemicalgrafting (cG™) is based on the same fundamental mechanisms as Electrografting, but is used on nonconductive substrates. Both technologies have been successfully demonstrated in manufacturing at and below the 14 nm node, as well as 40:1 aspect ratios. The company was originally founded in 2001 as a spinoff from the Commissariat à l’énergie atomique et aux énergies alternatives (CEA) to develop and market groundbreaking nanometric deposition technologies for a variety of electronic applications. Since that time, aveni has partnered with several R&D centers, and leading global equipment and device manufacturers on a variety of projects. Based in Massy, France, the company has a strong team of scientists and engineers who excel in the fields of surface science, chemistry, electrochemistry, physics, materials science and semiconductors.

Diabeloop

Series A in 2017
Diabeloop is a medical device company for diabetes and closed-loop system. It also develops disruptive technological innovations to automate the treatment of diabetes. The company mission is to make accessible disruptive technological innovations that will allow people with type 1 diabetes to live the life they want. Diabeloop was founded in 2015 and is headquartered in Grenoble, Auvergne-Rhône-Alpes, France.

Inpria

Series B in 2017
Inpria Corporation is a pioneer in extending semiconductor lithography with inorganic photoresists and other thin-films for nanoscale patterning. Inpria’s patented photo-condensed molecular oxides offer customers the unique ability to deposit – directly from solution – atomically smooth, intrinsically dense, and directly photopatternable metal oxide films, enabling advanced performance with simplified processing.

Ubleam

Seed Round in 2017
Ubleam helps manufacturers to increase their sales and customer knowledge with a smart mobile tag (bleam) for B2B services on mobile. More than 200 B2B customers use the bleam to for pro services on their product or improve maintenance processes in their industry. Awarded in France in 2015, Ubleam grows fast thanks to its BleamCard and IOT Platform to become the european leader in B2B Augmented Reality.

SBA Materials

Series D in 2015
SBA Materials is dedicated to the development of functional porous inorganic and inorganic/organic hybrid materials for a wide range of technologies. Different synthesis and processing conditions allow for a variety of material compositions, structures, and applications. They can be fabricated as thin and thick films, powders, fibers, and even optically clear solid monoliths all consisting of highly ordered mesoporous networks. The resulting surface area is extraordinarily high and can be chemically functionalized, e.g. with organic dyes, quantum dots, magnetic materials, or biomaterials enabling applications ranging from electronics and optics to sensors, catalysts. SBA Materials is located in Albuquerque, NM, at the Science and Technology Park, adjacent to the University of New Mexico and the Sandia National Laboratories Materials Research Center. The facility includes R&D laboratories, offices, and meeting space.

aveni

Series A in 2015
aveni delivers innovative metallization processes that improve device performance and yield, enabling future technologies, today. Their production-ready solutions revolutionize the copper-plating process for damascene and TSV applications critical to semiconductor and MEMS device manufacturing. aveni’s Electrografting (eG™) technology is a wet, electrochemical-based process that enables the growth of extremely high-quality thin films of various types. Chemicalgrafting (cG™) is based on the same fundamental mechanisms as Electrografting, but is used on nonconductive substrates. Both technologies have been successfully demonstrated in manufacturing at and below the 14 nm node, as well as 40:1 aspect ratios. The company was originally founded in 2001 as a spinoff from the Commissariat à l’énergie atomique et aux énergies alternatives (CEA) to develop and market groundbreaking nanometric deposition technologies for a variety of electronic applications. Since that time, aveni has partnered with several R&D centers, and leading global equipment and device manufacturers on a variety of projects. Based in Massy, France, the company has a strong team of scientists and engineers who excel in the fields of surface science, chemistry, electrochemistry, physics, materials science and semiconductors.

Water Planet

Series B in 2015
Water Planet is a Los Angeles based water treatment solutions provider focused on solving the world’s most challenging water reuse.

Xylowatt

Venture Round in 2014
XyloWatt specializes in the design, construction and management of cogeneration plants that use gasification of natural wood and recycled wood.

Hydrexia

Series B in 2013
Hydrexia is an Australian company that has successfully designed, built, and tested systems that stores hydrogen in solid form, based on a proprietary magnesium alloy.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.